Pharmaceutical composition for promoting angiogenesis
    1.
    发明申请
    Pharmaceutical composition for promoting angiogenesis 失效
    用于促进血管生成的药物组合物

    公开(公告)号:US20090187025A1

    公开(公告)日:2009-07-23

    申请号:US10587045

    申请日:2005-01-26

    IPC分类号: C07D211/34

    CPC分类号: A61K31/4468

    摘要: The present invention provides a pharmaceutical composition for promoting angiogenesis, which has an angiogenesis promoting action even in a vascular culturing system without effect of microcirculation. A pharmaceutical composition for promoting angiogenesis of the present invention comprises at least one compound selected from a group consisting of a piperidine compound represented by the general formula (1) or salts thereof: (wherein R represents a benzoyl group which may have, as substituents on the phenyl ring, 1 to 3 groups selected from a group consisting of an amino group, which may have a lower alkanoyl group, and a lower alkyl group; R1 represents a hydrogen atom or a lower alkyl group; and R2 represents a phenyl lower alkyl group).

    摘要翻译: 本发明提供一种用于促进血管生成的药物组合物,即使在不影响微循环的血管培养系统中也具有血管生成促进作用。 用于促进本发明的血管发生的药物组合物包含至少一种选自由通式(1)表示的哌啶化合物或其盐的化合物:其中R表示可以具有作为取代基的苯甲酰基 苯基环,可以具有低级烷酰基的氨基和低级烷基中的1〜3个基团; R 1表示氢原子或低级烷基; R 2表示苯基低级烷基 组)。

    METHOD FOR REDUCING INFARCTION USING VASOPRESSIN ANTAGONIST COMPOUNDS, AND COMPOSITIONS AND COMBINATIONS THEREFOR
    5.
    发明申请
    METHOD FOR REDUCING INFARCTION USING VASOPRESSIN ANTAGONIST COMPOUNDS, AND COMPOSITIONS AND COMBINATIONS THEREFOR 审中-公开
    使用血管紧张素拮抗剂化合物减少感染的方法及其组合物和组合

    公开(公告)号:US20080221084A1

    公开(公告)日:2008-09-11

    申请号:US11927153

    申请日:2007-10-29

    IPC分类号: A61K31/55 A61K31/551 A61P9/04

    CPC分类号: A61K31/55 A61K31/551

    摘要: The present invention relates to a method for reducing infarction comprising administering to a patient ion need thereof a therapeutically effective amount of a composition comprising as an active ingredient a vasopressin antagonist compound and to a composition useful therefor. The present invention also relates to a method for reducing infarction comprising administering to a patient in need thereof a therapeutically effective amount of a combination of a vasopressin antagonist compound and a beta-blocker and to combinations useful therefor. The methods, compositions and combinations of the present invention can be used for reducing infarction in the heart (myocardial infarction) and the brain (stroke). The methods, compositions and combinations of the present invention can also be used for the treatment and/or prevention of hypertension, edema, ascites, heart failure, renal function disorder, vasopressin inappropriate secretion syndrome (SIADH), hepatocirrhosis, hyponatremia, hypokalemia, polycystic kidney disease, diabetes, or circulation disorder.

    摘要翻译: 本发明涉及一种减少梗塞的方法,包括向患者施用离子需要量的治疗有效量的组合物,其包含作为活性成分的加压素拮抗剂化合物和用于其的组合物。 本发明还涉及一种减少梗塞的方法,其包括对有需要的患者施用治疗有效量的加压素拮抗剂化合物和β-阻断剂的组合以及对其有用的组合。 本发明的方法,组合物和组合可用于减少心脏(心肌梗死)和脑(中风)中的梗死。 本发明的方法,组合物和组合也可用于治疗和/或预防高血压,水肿,腹水,心力衰竭,肾功能障碍,加压素不适分泌综合征(SIADH),肝硬化,低钠血症,低钾血症,多囊性 肾脏疾病,糖尿病或循环障碍。

    Pharmaceutical composition for promoting angiogenesis

    公开(公告)号:US08445516B2

    公开(公告)日:2013-05-21

    申请号:US10587045

    申请日:2005-01-26

    IPC分类号: A61K31/4468

    CPC分类号: A61K31/4468

    摘要: The present invention provides a pharmaceutical composition for promoting angiogenesis, which has an angiogenesis promoting action even in a vascular culturing system without effect of microcirculation. A pharmaceutical composition for promoting angiogenesis of the present invention comprises at least one compound selected from a group consisting of a piperidine compound represented by the general formula (1) or salts thereof: (wherein R represents a benzoyl group which may have, as substituents on the phenyl ring, 1 to 3 groups selected from a group consisting of an amino group, which may have a lower alkanoyl group, and a lower alkyl group; R1 represents a hydrogen atom or a lower alkyl group; and R2 represents a phenyl lower alkyl group).